Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2006

Apr 7, 2006

30339_dirs_2006-04-07_60df0b53-f1d2-4070-85de-cbadbd00a64a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-02-24

Reporting Person: HARGESHEIMER ROBERT S (Div Pres-Pharma Device Group)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-02-24 Common Stock A 691.4965 $32.5850 Acquired 33456.3069 Direct
2006-02-24 Common Stock A 1100 Acquired 34556.3069 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-02-24 Stock Option (Right to Buy) $32.5850 A 9282 Acquired 2016-02-24 Common Stock (9282.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4315.8090 Indirect

Footnotes

F1: Bonus and incentive shares granted on 2/24/06.

F2: Additional amount of shares due to achieving above targeted amount for first performance period of 3/7/05 Performance Vested Restricted Share grant.

F3: The reporting person mistakenly filed a Form 4 reporting an acquisition of 3,173 shares of common stock on 2/24/2006 that did not in fact occur. [On that date the Reporting Person was granted performance [shares/units] which are not reportable unless and until certain performance vesting requirements (not tied to stock price) are met.] As of 2/24/2006, the Reporting Person owned only 34,556.3069 shares of common stock.

F4: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.